One of the plaintiffs is Lisbeth Ceriani, a 43-year-old woman with breast cancer whose doctors recommended that she be tested for two genetic mutations involved in some hereditary forms of the disease. Myriad Genetics, the sole test provider in the US – it holds a patent on the genes themselves , not just on the diagnostic test – did not accept her insurance, and Ceriani could not afford to pay for the test.